Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.
Med Chem. 2020;16(3):272-306. doi: 10.2174/1573406415666190416121448.
Coumarins exhibit a plethora of biological activities, e.g. antiinflammatory and anti-tumor. Molecular hybridization technique has been implemented in the design of novel coumarin hybrids with several bioactive groups in order to obtain molecules with better pharmacological activity and improved pharmacokinetic profile.
Therefore, we tried to gather as many as possible biologically active coumarin hybrids referred in the literature till now, to delineate the structural characteristics in relation to the activities and to have a survey that might help the medicinal chemists to design new coumarin hybrids with drug-likeness and varied bioactivities.
The biological activities of the hybrids in most of the cases were found to be different from the biological activities presented by the parent coumarins. The results showed that the hybrid molecules are more potent compared to the standard drugs used in the evaluation experiments.
Conjugation of coumarin with varied pharmacophore groups/druglike molecules responsible for different biological activities led to many novel hybrid molecules, with a multitarget behavior and improved pharmacokinetic properties.
香豆素具有多种生物活性,例如抗炎和抗肿瘤。为了获得具有更好药理活性和改善药代动力学特征的分子,已经将分子杂交技术应用于设计具有多种生物活性基团的新型香豆素杂合子中。
因此,我们试图尽可能多地收集迄今为止文献中提到的具有生物活性的香豆素杂合体,以阐明与活性相关的结构特征,并进行调查,这可能有助于药物化学家设计具有类药性和多种生物活性的新型香豆素杂合体。
在大多数情况下,杂合体的生物活性与母体香豆素所呈现的生物活性不同。结果表明,与用于评估实验的标准药物相比,杂合分子的活性更强。
将香豆素与负责不同生物活性的各种药效团/类药分子缀合,得到了许多具有多靶性行为和改善药代动力学性质的新型杂合分子。